Pharma-Bio Serv (PBSV) Liabilities from Discontinued Operations (2017)
Pharma-Bio Serv's (PBSV) quarterly Liabilities from Discontinued Operations came in at 110206.0 in Q4 2017.
Pharma-Bio Serv (PBSV) Liabilities from Discontinued Operations (2017) Analysis & Trends
Pharma-Bio Serv (PBSV) has 1 years of Liabilities from Discontinued Operations data on file, last reported at 110206.0 in Q4 2017.
- Quarterly Liabilities from Discontinued Operations changed N/A year-over-year to 110206.0 in Q4 2017, while the trailing twelve-month figure through Oct 2017 was 110206.0 (changed N/A YoY) and the FY2017 annual result came in at 110206.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations steadied at 110206.0 in Q4 2017.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of 110206.0 in Q4 2017 to a low of 110206.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2017 | 110,206.00 |
| Oct 31, 2017 | 110,206.00 |